This study evaluates the therapeutic potential of Asystasia vogeliana (AV) aqueous leaf extract on the expression of vascular cell adhesion molecule (VCAM) and the tumor suppressor protein p53 in the cardiac tissue of rats rendered anemic with 2,4-dinitrophenylhydrazine (DNPH). Forty rats were randomly assigned to five groups: a normal control group, a DNPH-induced group without treatment, two DNPH-induced groups receiving AV extract at 200 and 400 mg/kg body weight, and a DNPH-induced group treated with 200 mg/kg of vitamin B12 as a standard reference. All treatments lasted for 29 days. At the conclusion of the study, the animals were sacrificed, and their heart tissues were harvested for biochemical and molecular assessments. Serum lipid profiles and expression levels of VCAM and p53 proteins were assessed. The results showed that AV-treated anemic rats exhibited significant improvements in lipid parameters and a marked downregulation of VCAM and p53 expression compared to untreated anemic rats (p < 0.05). Additionally, a reduction in pro-inflammatory cytokines associated with cardiac injury was observed. These findings suggest that A. vogeliana aqueous extract may have cardioprotective and anti-inflammatory effects in anemia-induced cardiac damage. Further investigations are warranted to fully elucidate its mechanisms and therapeutic potential.
- Open Access
- Article
Cardioprotective Effects of the Aqueous Leaf Extract of Asystasia vogeliana via Modulation of VCAM-1 and p53 in Anemia-Induced Rats
- Basiru Olaitan Ajiboye 1,
- Olawale Razaq Ajuwon 2,
- Abdullateef Olamide Babalola 1,
- Damilare Emmanuel Bamigboye 1,
- Olumide Adebola Alonge 1,
- Oluwatosin Aliu 1,
- Raimot Olabisi Ojedokun 3,
- Sunday Abimbade 4,
- Mary Abiola Okesola 5,
- Precious Eseose Agboinghale 6,
- Ajoke Fehintola Idayat Akindele 7,
- Oluwafemi Adeleke Ojo 8,
- Babatunji Emmanuel Oyinloye 9 and
- Gamal Moustafa Mahmoud Abdelfattah 10,*
Author Information
Received: 28 June 2026 | Revised: 15 October 2026 | Accepted: 19 October 2026 | Published: 09 November 2026
Abstract
Keywords
Asystasia vogeliana | cardiac injury | 2,4-dinitrophenylhydrazine | liver damage | gene expression
References
- 1.
Popoola, J.O.; Adebayo, H.A.; Taiwo, O.S.; et al. Studies on Local Knowledge and In vitro Cytotoxicity of Moringa oleifera L., Andrographis paniculata N. and Asystasia vogeliana B. Extracts. Res. J. Appl. Sci. 2017, 12, 180–190.
- 2.
Ugwuanyi, E.H.; Samuel, C.U.; Madubunyi, I.I. In vitro antioxidant potentials and hepatoprotective effects of Asystasia vogeliana (Benth) leaf extracts against paracetamol-induced hepatic injury in rats. J. Exp. Biol. Agric. Sci. 2020, 8, 839–848. https://doi.org/10.18006/2020.8(6).839.848.
- 3.
Akinlolu, O.; Oseni, O.; Fatoki, T.; et al. In vitro comparative antioxidant potentials of cold and hot aqueous extracts of Asystasia vogeliana Benth. Trop. J. Eng. Sci. Technol. 2022, 1, 62–71.
- 4.
Godwin, A.; Ojelabi, O.M.; Romanus, M.R.; et al. Preliminary Investigation of Skin Protection Potential of Partially Purified Leaf Fraction of Asystasia vogeliana Benth. Adeleke Univ. J. Sci. 2022, 1, 197–209.
- 5.
Kong, D.H.; Kim, Y.; Kim, M.; et al. Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. Int. J. Mol. Sci. 2018, 19, 1057. https://doi.org/10.3390/ijms19041057.
- 6.
Ridker, P.M. Intercellular adhesion molecule (ICAM-1) and the risks of developing atherosclerotic disease. Eur. Heart J. 1998, 19, 1119–1121.
- 7.
Morisaki, N.; Saito, I.; Tamura, K.; et al. New indices of ischemic heart disease and aging: Studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis 1997, 131, 43–48. https://doi.org/10.1016/s0021-9150(97)06083-8.
- 8.
Riley, T.; Sontag, E.; Chen, P.; et al. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 2008, 9, 402–412. https://doi.org/10.1038/nrm2395.
- 9.
Wei, M.C.; Zong, W.X.; Cheng, E.H.Y.; et al. Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death. Science 2001, 292, 727–730. https://doi.org/10.1126/science.1059108.
- 10.
Udeozor, P.A.; Ibiam, U.A.; Uti, D.E.; et al. Antioxidant and Anti-Anemic Effects of Ethanol Leaf Extracts of Mucuna poggei and Telfairia occidentalis in Phenyl-Hydrazine-Induced Anemia in Wistar Albino Rats. Ibnosina J. Med. Biomed. Sci. 2022, 14, 116–126. https://doi.org/10.1055/s-0042-1756684.
- 11.
Yokozawa, T.; Cho, E.J.; Sasaki, S.; et al. The Protective Role of Chinese Prescription Kangen-karyu Extract on Diet-Induced Hypercholesterolemia in Rats. Biol. Pharm. Bull. 2006, 29, 760–765. https://doi.org/10.1248/bpb.29.760.
- 12.
Bewaji, C.O.; Olorunsogo, O.O.; Bababunmi, E.A. Comparison of the membrane-bound (Ca2+ + Mg2+)-ATPase in erythrocyte ghosts from some mammalian species. Comp. Biochem. Physiol. Part B Comp. Biochem. 1985, 82, 117–122. https://doi.org/10.1016/0305-0491(85)90138-5.
- 13.
Sheth, P.A.; Pawar, A.T.; Mote, C.S.; et al. Antianemic activity of polyherbal formulation, Raktavardhak Kadha, against phenylhydrazine-induced anemia in rats. J. Ayurveda Integr. Med. 2021, 12, 340–345. https://doi.org/10.1016/j.jaim.2021.02.009.
- 14.
Apak, R.; Capanoglu, E.; Shahidi, F. (Eds.) Measurement of Antioxidant Activity and Capacity: Recent Trends and Applications; John Wiley & Sons Ltd.: Hoboken, NJ, USA, 2018; pp. 107–117.
- 15.
Maurya, A.P.; Chauhan, J.; Yadav, D.K.; et al. Nutraceuticals and their impact on human health. In Preparation of Phytopharmaceuticals for the Management of Disorders; Elsevier: Amsterdam, The Netherlands, 2021; pp. 229–254. https://doi.org/10.1016/b978-0-12-820284-5.00011-3.
- 16.
Hunter, K.J.; Fletcher, J.M. The antioxidant activity and composition of fresh, frozen, jarred and canned vegetables. Innov. Food Sci. Emerg. Technol. 2002, 3, 399–406. https://doi.org/10.1016/s1466-8564(02)00048-6.
- 17.
Gupta, S.; Prakash, J. Studies on Indian Green Leafy Vegetables for Their Antioxidant Activity. Plant Foods Hum. Nutr. 2009, 64, 39–45. https://doi.org/10.1007/s11130-008-0096-6.
- 18.
Hernández-Rodríguez, P.; Baquero, L.P.; Larrota, H.R. Flavonoids: Potential therapeutic agents by their antioxidant capacity. In Bioactive Compounds: Health Benefits and Potential Applications; Elsevier: Amsterdam, The Netherlands, 2019; pp. 265–288. https://doi.org/10.1016/b978-0-12-814774-0.00014-1.
- 19.
Ajiboye, B.O.; Famusiwa, C.D.; Falode, J.A.; et al. Ocimum gratissimum L. leaf flavonoid-rich extracts reduced the expression of p53 and VCAM in streptozotocin-induced cardiomyopathy rats. Phytomed. Plus 2024, 4, 100548. https://doi.org/10.1016/j.phyplu.2024.100548.
- 20.
Chattopadhyay, R.R.; Bandyopadhyay, M. Effect of Azadirachta indica leaf extract on serum lipid profile changes in normal and streptozotocin induced diabetic rats. Afr. J. Biomed. Res. 2006, 8, 101–104. https://doi.org/10.4314/ajbr.v8i2.35769.
- 21.
Gentile, M.; Iannuzzi, A.; Giallauria, F.; et al. Association between Very Low-Density Lipoprotein Cholesterol (VLDL-C) and Carotid Intima-Media Thickness in Postmenopausal Women without Overt Cardiovascular Disease and on LDL-C Target Levels. J. Clin. Med. 2020, 9, 1422. https://doi.org/10.3390/jcm9051422.
- 22.
Mielke, M.M.; Zandi, P.P.; Shao, H.; et al. The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology 2010, 75, 1888–1895. https://doi.org/10.1212/wnl.0b013e3181feb2bf.
- 23.
Barter, P.J.; Nicholls, S.; Rye, K.A.; et al. Antiinflammatory Properties of HDL. Circ. Res. 2004, 95, 764–772. https://doi.org/10.1161/01.res.0000146094.59640.13.
- 24.
Baigent, C.; Blackwell, L.; Emberson, J.; et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010, 376, 1670–1681. https://doi.org/10.1016/s0140-6736(10)61350-5.
- 25.
Dobiášová, M. Atherogenic Impact of Lecithin-Cholesterol Acyltransferase and Its Relation to Cholesterol Esterification Rate in HDL (FERHDL) and AIP [log(TG/HDL-C)] Biomarkers: The Butterfly Effect? Physiol. Res. 2017, 66, 193–203. https://doi.org/10.33549/physiolres.933621.
- 26.
Bull, H.; Murray, P.G.; Thomas, D.; et al. Acid phosphatases. Mol. Pathol. 2002, 55, 65–72. https://doi.org/10.1136/mp.55.2.65.
- 27.
Ndrepepa, G. Alkaline phosphatase and cardiovascular disease. J. Lab. Precis. Med. 2017, 2, 83. https://doi.org/10.21037/jlpm.2017.10.02.
- 28.
Hamilton, S.; Terentyev, D. ER stress and calcium-dependent arrhythmias. Front. Physiol. 2022, 13, 1041940. https://doi.org/10.3389/fphys.2022.1041940.
- 29.
Horáková, L.; Strosova, M.K.; Spickett, C.M.; et al. Impairment of calcium ATPases by high glucose and potential pharmacological protection. Free Radic. Res. 2013, 47, 81–92. https://doi.org/10.3109/10715762.2013.807923.
- 30.
Younus, H. Therapeutic potentials of superoxide dismutase. Int. J. Health Sci. 2018, 12, 88–93.
- 31.
Berk, M.; Copolov, D.; Dean, O.; et al. N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial. Biol. Psychiatry 2008, 64, 361–368. https://doi.org/10.1016/j.biopsych.2008.03.004.
- 32.
Lakhdar, R.; Denden, S.; Mouhamed, M.H.; et al. Correlation of EPHX1, GSTP1, GSTM1, and GSTT1 genetic polymorphisms with antioxidative stress markers in chronic obstructive pulmonary disease. Exp. Lung Res. 2011, 37, 195–204. https://doi.org/10.3109/01902148.2010.535093.
- 33.
Cui, X.; Gong, J.; Han, H.; et al. Relationship between free and total malondialdehyde, a well-established marker of oxidative stress, in various types of human biospecimens. J. Thorac. Dis. 2018, 10, 3088–3097. https://doi.org/10.21037/jtd.2018.05.92.
- 34.
Misra, U.K.; Kalita, J.; Singh, S.K.; et al. Oxidative Stress Markers in Vitamin B12 Deficiency. Mol. Neurobiol. 2017, 54, 1278–1284. https://doi.org/10.1007/s12035-016-9736-2.
- 35.
Musaya, J.; Matovu, E.; Nyirenda, M.; et al. Role of Cytokines in Trypanosoma brucei-Induced Anaemia: A Review of the Literature. Malawi Med. J. 2015, 27, 45–50. https://doi.org/10.4314/mmj.v27i2.3.
- 36.
Zangeneh, M.M.; Pooyanmehr, M.; Zangeneh, A. Evaluation of the anti-anemic potential of Glycyrrhiza glabra aqueous extract in Phenylhydrazine-treated rats. Iran. J. Pharmacol. Ther. 2017, 15, 1–9.
- 37.
Cybulsky, M.I.; Iiyama, K.; Li, H.; et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Investig. 2001, 107, 1255–1262. https://doi.org/10.1172/jci11871.
- 38.
Marei, H.E.; Althani, A.; Afifi, N.; et al. p53 signaling in cancer progression and therapy. Cancer Cell Int. 2021, 21, 703. https://doi.org/10.1186/s12935-021-02396-8.
This work is licensed under a Creative Commons Attribution 4.0 International License.
